【ChiCTR2500114733】Assessment of Cytotoxicity, Genotoxicity in Exfoliated Buccal Mucosa Cells following OPG and CBCT
ChiCTR2500114733
结束
/
/
/
2025-12-17
/
/
The genotoxicity of x ray
Assessment of Cytotoxicity, Genotoxicity in Exfoliated Buccal Mucosa Cells following OPG and CBCT
The ResearchOf Cytotoxicity, Genotoxicity And Oxidative Stress Response On Exfoliated Buccal Mucosa Cells Upon OPG And CBCTRadiations Exposure Across Two Different Age Groups
25000
General: To determine the association between the age and effect of X-ray radiation. Specific: 1.To assess the oxidative stress responses of different X-ray radiation doses on exfoliated buccal epithelial cells. 2.To explore the effect of different radiation does on exfoliated stress responses on exfoliated buccal epithelial cells.(OPG, CBCT)
连续入组
其它
N/A
/
In Vitro Research Of Oxy-Ionic Solution: Cytotocity Study On Human Periodontal Ligament Fibroblast Cell Line and Antimicrobial Effect On Streptococcus Mutans [R504-LR-GAL007-0000000168-Y120]
/
180
/
2024-09-17
2025-09-30
/
1. Individuals with no harmful habits such as smoking, alcohol consumption and/or betel nut chewing. 2. Individuals who have not been exposed to X-rays in the past three months and will undergo dental X-ray examination within one hour. 3. No oral mucosal diseases. 4. No local irritating factors.；
请登录查看Patients who do not meet all of the above inclusion criteria and exhibit any of the following characteristics will be excluded: 1. Systemic diseases such as leukemia, lymphoma, rheumatic diseases, diabetes, etc. 2. History of treatments such as head and neck radiation therapy, immunosuppressive, or cytotoxic drugs. 3. Individuals with infectious diseases or inflammatory conditions. 4. Local pathological changes, such as macroscopic abnormalities, gum and periodontal diseases. 5. Pregnant women. 6. Individuals wearing removable dentures or intra-oral appliance.；
请登录查看Universiti Sains Malaysia
25000
Universiti Sains Malaysia的其他临床试验
Universiti Sains Malaysia Kampus Kesihatan的其他临床试验
最新临床资讯
-
全球首个mRNA癌症疗法III期阳性！intismeran联合帕博利珠单抗显著改善黑色素瘤术后复发风险，个体化新抗原获确切证据
良医汇肿瘤资讯2026-08-30
-
PFS突破30个月:HORIZON-Breast01证实瑞康曲妥珠单抗实现HER2精准治疗新突破
良医汇肿瘤资讯2026-08-30
-
良医汇肿瘤资讯2026-08-30
-
良医汇肿瘤资讯2026-08-30
-
歌礼2026-08-30
-
良医汇血液肿瘤资讯2026-08-30
-
医麦客2026-08-30
-
良医汇血液肿瘤资讯2026-08-29
-
蒲公英Ouryao2026-08-29
-
凡默谷2026-08-29
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-30
-
2026-08-30
-
2026-08-30
-
摩熵咨询 20 8
-
摩熵咨询 34 36
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-31
-
2026-08-30
-
2026-08-29
-
摩熵咨询 35 45
-
摩熵咨询 28 45
-
摩熵咨询 34 24
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29